LOS ANGELES -- The FDA's warning about arrhythmia risk with lamotrigine (Lamictal) based on in vitro data wasn't borne out in observational cohorts of people with epilepsy, although the risk did ...

The FDA on Wednesday updated its warning about potential increased arrhythmia risk in people with cardiac disease who are taking the seizure and mental health drug lamotrigine (Lamictal) with new data ...

May 4, 2010 — Lamotrigine is the most effective antiepileptic drug (AED) in older adults with epilepsy, with levetiracetam a close second, according to the results of a retrospective review of 10 AEDs ...

Boston, MA, May 1, 2007 -- Data from two clinical trials presented today at the American Academy of Neurology (AAN) meeting suggest that an investigational once daily extended release formulation of ...

Research Triangle Park, NC (January 20, 2002) – GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) granted marketing clearance for Lamictal® (lamotrigine) Tablets as ...

April 26, 2011 — The US Food and Drug Administration has approved lamotrigine extended release for conversion to monotherapy for partial seizures. This is a new indication for the GlaxoSmithKline ...

About 60-70% of focal epilepsy patients achieve seizure control with first-line antiseizure medications (ASMs). Lamotrigine and levetiracetam demonstrate high efficacy and tolerability for seizure ...

Generic lamictal 25 mg — legally. Extended-release lamotrigine is used in combination with other anticonvulsant agents in the management of partial seizures, with or without secondary generalization, ...

People with epilepsy are at risk for hypertension, atrial fibrillation, and hyperlipidemia; they also have an elevated risk ...

In honor of Epilepsy Awareness Month, experts highlight the importance of managing in utero exposure to anti-seizure medications during pregnancy.

Purpose: We analyzed seizure frequencies before and during Lamotrigine (LTG) treatment of children with special focus on the etiology of their epilepsy syndrome. Methods: Patient data were documented ...

Common side effects include sleepiness, headache, vomiting, trouble with coordination, and rash. Lamotrigine was first marketed in the United Kingdom in, and approved for use in the United States in ...